Immediate HIV Treatment Initiation With Integrase Inhibitors Leads to Large Drop in Secondary HIV Transmission Among MSM
Integrase inhibitors are known to be potent first-line therapy options. Recent research suggests their benefits extend to onward HIV prevention as well.
Open conversations between care providers and Black women are vitally important in order to empower women with information about HIV and how to protect their health.
A revolution in organ transplants is taking place.
June 18, 2020: Existing evidence-based interventions aren't enough to close HIV's racial gap; transgender patient outcomes in the HIV care continuum; meeting long-term needs of formerly incarcerated people; acute respiratory illness severity and HIV status.
June 11, 2020: Diagnosis rates within a year of infection; rates of intentional non-daily PrEP use; neurological development in children of birth parents with HIV; point-of-care urine test to assess tenofovir levels.
Recent studies examine the role anal sex is playing in HIV rates and anal cancer among women.
This researcher has some ideas about what we need to do to address the problem.
May 7, 2020: Epidemiological factors among transgender women; revised PrEP indication estimates for MSM; trends in HIV strain similarity between younger and older MSM; current hepatitis C epidemic among British MSM with HIV.
HVTN 702 may not have proven an effective vaccine, but scientists still learned from the research.
COVID-19 will impact both the program content and attendees this year, but there are still important HIV science presentations.